Cargando…
Inflammatory Response in COVID-19 Patients Resulting from the Interaction of the Inflammasome and SARS-CoV-2
The outbreak of the coronavirus disease 2019 (COVID-19) began at the end of 2019. COVID-19 is caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and patients with COVID-19 may exhibit poor clinical outcomes. Some patients with severe COVID-19 experience cytokin...
Autores principales: | Cheon, So Yeong, Koo, Bon-Nyeo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348456/ https://www.ncbi.nlm.nih.gov/pubmed/34360684 http://dx.doi.org/10.3390/ijms22157914 |
Ejemplares similares
-
Inflammasome and Cognitive Symptoms in Human Diseases: Biological Evidence from Experimental Research
por: Cheon, So Yeong, et al.
Publicado: (2020) -
Hyperammonemia induces microglial NLRP3 inflammasome activation via mitochondrial oxidative stress in hepatic encephalopathy
por: Cheon, So Yeong, et al.
Publicado: (2023) -
Cell Type-Specific Mechanisms in the Pathogenesis of Ischemic Stroke: The Role of Apoptosis Signal-Regulating Kinase 1
por: Cheon, So Yeong, et al.
Publicado: (2018) -
Inflammasomes and SARS-CoV-2 Infection
por: Kaivola, Juha, et al.
Publicado: (2021) -
SARS-CoV-2 mutations acquired during serial passage in human cell lines are consistent with several of those found in recent natural SARS-CoV-2 variants
por: Chung, Hoyin, et al.
Publicado: (2022)